Investors

Vivione Biosciences Inc. Announces Appointment of Officers, Grant of Stock Options and Proposed Private Placement

FIND OUT MORE

Applications

Vivione Biosciences has applications of interest to the Food Safety, Industrial Microbiology, and Clinical Infectious Disease areas.

FIND OUT MORE

How it works

Co-developed with the FDA National Center for Toxicological Research, RAPID-B has some unique capabilities.

FIND OUT MORE

News Feed

Vivione Biosciences signs agreement with CMS Technology

Vivione Biosciences Inc. chief executive officer interviewed by CEOCFO Magazine

Vivione Biosciences announces closing of the private placement offering with the arkansas venture capital

Vivione Biosciences Inc. forms strategic alliance with AriBio, Inc.

Vivione Biosciences Inc. Announces Appointment of Officers, Grant of Stock Options and Proposed Private Placement

FDA and Vivione Enter into a New Three-Year Cooperative Research and Development Agreement

Vivione Biosciences set for food safety breakthrough

Vivione Biosciences In Position for a Big Year

Vivione Biosciences Inc. is pleased to announce a new development relationship

Vivione Biosciences Inc. signs collaboration with University of Arkansas Department

Number of U.S. Foodborne Illness Cases Stalled: CDC

E. Coli  Fears Prompt Massive Frozen Food Recall